Literature DB >> 31221356

Variability of Sleep Apnea Severity and Risk of Atrial Fibrillation: The VARIOSA-AF Study.

Dominik Linz1, Anthony G Brooks2, Adrian D Elliott1, Chrishan J Nalliah3, Jeroen M L Hendriks1, Melissa E Middeldorp1, Celine Gallagher1, Rajiv Mahajan1, Jonathan M Kalman3, R Doug McEvoy4, Dennis H Lau1, Prashanthan Sanders5.   

Abstract

OBJECTIVES: This study sought to determine night-to-night variability in the severity of sleep-disordered breathing (SDB) and the dynamic intraindividual relationship to daily risk of incident atrial fibrillation (AF) by using simultaneous long-term day-by-day SDB and AF monitoring.
BACKGROUND: Night-to-night variability in SDB severity may result in a dynamic exposure to SDB related conditions impacting the timing and extent of cardiovascular responses.
METHODS: This study was an observational cohort study. Daily data for AF burden and average respiratory disturbance index (RDI) were extracted from pacemakers capable of monitoring nightly SDB and daily AF burden in 72 patients. Nightly RDI values were grouped into quartiles of severity within each patient. AF burdens of >5 min, >1 h, and >12 h were the outcome variables.
RESULTS: A total of 32% of patients had a mean RDI of ≥20/h, indicative of overall severe SDB. There was significant night-to-night variation in RDI reflected by an absolute SD of ±6.3 events/h (range 2 to 14 events/h) within any given patient. Within each patient, the nights with the highest RDI (in their highest quartile) conferred a 1.7-fold (1.2 to 2.2; p < 0.001), 2.3-fold (1.6 to 3.5; p < 0.001), and 10.2-fold (3.5 to 29.9; p < 0.001) increase risk of having at least 5 min, 1 h, and 12 h, respectively, of AF during the same day compared with the best sleep nights (in their lowest quartiles).
CONCLUSIONS: There is considerable night-to-night variability in SDB severity which cannot be detected by 1 single overnight sleep study. SDB burden may be a better metric with which to assess the extent of dynamic SDB related cardiovascular responses such as daily AF risk than the categorical diagnosis of SDB. (Night-to-Night Variability in Severity of Sleep Apnea and Daily Dynamic Atrial Fibrillation Risk [VARIOSA-AF]; ACTRN 12618000757213). Crown
Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; burden; dynamic substrate; night-to-night variability; pacemaker; sleep-disordered breathing

Year:  2019        PMID: 31221356     DOI: 10.1016/j.jacep.2019.03.005

Source DB:  PubMed          Journal:  JACC Clin Electrophysiol        ISSN: 2405-500X


  15 in total

1.  Obstructive sleep apnea and nocturnal attacks of paroxysmal atrial fibrillation.

Authors:  Chou-Han Lin; Maria Timofeeva; Tara O'Brien; Owen D Lyons
Journal:  J Clin Sleep Med       Date:  2022-05-01       Impact factor: 4.324

2.  Risk profiling in atrial fibrillation: Value of assessment of vascular blush.

Authors:  Kashif B Khokhar; Dennis H Lau; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-11

Review 3.  Nightly sleep apnea severity in patients with atrial fibrillation: Potential applications of long-term sleep apnea monitoring.

Authors:  Dominik Linz; Mathias Baumert; Lien Desteghe; Kadhim Kadhim; Kevin Vernooy; Jonathan M Kalman; Dobromir Dobrev; Michael Arzt; Manu Sastry; Harry J G M Crijns; Ulrich Schotten; Martin R Cowie; R Doug McEvoy; Hein Heidbuchel; Jeroen Hendriks; Prashanthan Sanders; Dennis H Lau
Journal:  Int J Cardiol Heart Vasc       Date:  2019-10-18

Review 4.  On-demand mobile health infrastructures to allow comprehensive remote atrial fibrillation and risk factor management through teleconsultation.

Authors:  Astrid N L Hermans; Rachel M J van der Velden; Monika Gawalko; Dominique V M Verhaert; Lien Desteghe; David Duncker; Martin Manninger; Hein Heidbuchel; Ron Pisters; Martin Hemels; Laurent Pison; Afzal Sohaib; Arian Sultan; Daniel Steven; Petra Wijtvliet; Robert Tieleman; Dhiraj Gupta; Dobromir Dobrev; Emma Svennberg; Harry J G M Crijns; Nikki A H A Pluymaekers; Jeroen M Hendriks; Dominik Linz
Journal:  Clin Cardiol       Date:  2020-10-08       Impact factor: 2.882

5.  Passive longitudinal weight and cardiopulmonary monitoring in the home bed.

Authors:  Nicholas Harrington; Quan M Bui; Zhe Wei; Brandon Hernandez-Pacheco; Pamela N DeYoung; Andrew Wassell; Bayan Duwaik; Akshay S Desai; Deepak L Bhatt; Parag Agnihotri; Robert L Owens; Todd P Coleman; Kevin R King
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.996

6.  Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea.

Authors:  Bastien Lechat; Ganesh Naik; Amy Reynolds; Atqiya Aishah; Hannah Scott; Kelly A Loffler; Andrew Vakulin; Pierre Escourrou; R Doug McEvoy; Robert J Adams; Peter G Catcheside; Danny J Eckert
Journal:  Am J Respir Crit Care Med       Date:  2022-03-01       Impact factor: 30.528

7.  Sleep apnea in atrial fibrillation - Highly prevalent, highly relevant, but most patients are not somnolent!

Authors:  Kadhim Kadhim; Dennis H Lau; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2020-01-06

8.  Prevalence, risk factors, and type of sleep apnea in patients with paroxysmal atrial fibrillation.

Authors:  G M Traaen; B Øverland; L Aakerøy; T E Hunt; C Bendz; L Sande; S Aakhus; H Zaré; S Steinshamn; O G Anfinsen; J P Loennechen; L Gullestad; H Akre
Journal:  Int J Cardiol Heart Vasc       Date:  2019-12-19

9.  Gender differences and daily variation in atrial fibrillation risk factor profiles: Considerations for risk factor management.

Authors:  Nikki A H A Pluymaekers; Astrid N L Hermans; Melissa E Middeldorp; Kadhim Kadhim; Harry J G M Crijns; Prashanthan Sanders; Dominik Linz
Journal:  Int J Cardiol Heart Vasc       Date:  2019-11-19

10.  Continuous monitoring of sleep-disordered breathing with pacemakers: Indexes for risk stratification of atrial fibrillation and risk of stroke.

Authors:  Andrea Mazza; Maria Grazia Bendini; Massimo Leggio; Raffaele De Cristofaro; Sergio Valsecchi; Giuseppe Boriani
Journal:  Clin Cardiol       Date:  2020-11-12       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.